![Connie Matsui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Connie Matsui
Vorsitzender bei
ARTELO BIOSCIENCES, INC.
Vermögen: 146 444 $ am 31.05.2026
Profil
Connie L. Matsui ist Vorsitzende bei Sutro Biopharma, Inc. und bei Artelo Biosciences, Inc. sowie Vorsitzende bei Halozyme Therapeutics, Inc. und bei Balboa Park Conservancy. Frau Matsui war zuvor als National President bei Girl Scouts of the USA, als Executive Vice President bei Biogen Idec New Ventures, Inc., als Senior Vice President bei IDEC Pharmaceuticals Corp., als Executive VP-Knowledge & Innovation Networks bei Biogen Idec, Inc. und als President & Chief Executive Officer bei The San Diego Foundation tätig. Sie erhielt ihren Bachelor-Abschluss von der Stanford University und einen MBA von der Stanford University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC. 0,03 % | 05.06.2026 | 5.000 ( 0,03 % ) | 146 150 $ | 31.05.2026 |
ARTELO BIOSCIENCES INC 0,01 % | 20.02.2026 | 210 ( 0,01 % ) | 294 $ | 31.05.2026 |
Aktive Positionen von Connie Matsui
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Vorsitzender | 02.05.2017 |
| SUTRO BIOPHARMA, INC. | Vorsitzender | 24.06.2019 |
Ehemalige bekannte Positionen von Connie Matsui
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Vorsitzender | - |
The San Diego Foundation
 The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Vorstandsvorsitzender | 01.05.2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2009 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01.01.2009 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Corporate Officer/Principal | 31.03.2008 |
Ausbildung von Connie Matsui
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The San Diego Foundation
The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Commercial Services |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Girl Scouts of the USA
 Girl Scouts of the USA Miscellaneous Commercial ServicesCommercial Services Helps to build character and skills for girls | Commercial Services |
Balboa Park Conservancy
 Balboa Park Conservancy Miscellaneous Commercial ServicesCommercial Services Provides advocacy services | Commercial Services |
